Multiple Myeloma and IV Bisphosphonate Are Risk Factors for Osteonecrosis of the Jaw

被引:0
|
作者
Tennis, Pat [1 ]
Rothman, Kenneth J. [1 ]
Bohn, Rhonda [2 ]
Tan, Hiangkat [2 ]
Anthony, Mary [3 ]
Zavras, Athanosios [4 ]
Calingaert, Brian [1 ]
机构
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
[2] Healthcore Inc, Wilmington, DE USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
[4] Columbia Univ, New York, NY USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
741
引用
收藏
页码:S313 / S314
页数:2
相关论文
共 50 条
  • [21] Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer
    Van Poznak, Catherine
    Reynolds, Evan L.
    Estilo, Cherry L.
    Hu, Mimi
    Schneider, Bryan Paul
    Hertz, Daniel L.
    Gersch, Christina
    Thibert, Jacklyn
    Thomas, Dafydd
    Banerjee, Mousumi
    Rae, James M.
    Hayes, Daniel F.
    ORAL DISEASES, 2022, 28 (01) : 193 - 201
  • [22] Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy
    Wang, Estee P.
    Kaban, Leonard B.
    Strewler, Gordonj
    Raje, Noopur
    Troulis, Maria J.
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2007, 65 (07) : 1328 - 1331
  • [23] Cytokine Alteration In Multiple Myeloma (MM) Patients and Bisphosphonate (BP)-Related Osteonecrosis Of The Jaw (BRONJ)
    Badros, Ashraf
    Philip, Sunita
    Lesho, Patricia
    Sadowska, Mariola
    Weikel, Dianna
    Meiller, Timothy
    Lapidus, Rena
    Hester, Lisa
    Milliron, Todd
    Goloubeva, Olga
    BLOOD, 2013, 122 (21)
  • [24] Clinical, radiographic, and biomarker characterization of multiple myeloma patients with bisphosphonate associated osteonecrosis of the jaw.
    Raje, Noopur
    Woo, Sook-Bin
    Hande, Karen
    Yap, Jeffrey T.
    Richardson, Paul G.
    Vallet, Sonia
    Treister, Nathaniel
    Hideshima, Teru
    Tai, Yu-Tzu
    Chhetri, Shweta
    Connell, Brendan
    Szot-Barnes, Agnieszka
    Tian, Mei
    Schlossman, Robert L.
    Weeler, Edie
    Munshi, Nikhil C.
    Van Den Abbeele, Annick D.
    Anderson, Kenneth C.
    BLOOD, 2006, 108 (11) : 1025A - 1026A
  • [25] Concomitant Factors Leading to an Atypical Osteonecrosis of the Jaw in a Patient with Multiple Myeloma
    Miranda-Rius, Jaume
    Brunet-Llobet, Lluis
    Lahor-Soler, Eduard
    Anton Gimenez-Rubio, Josep
    CASE REPORTS IN MEDICINE, 2014, 2014
  • [26] Factors associated with osteonecrosis of the jaw among bisphosphonate users
    Hess, Lisa M.
    Jeter, Joanne M.
    Benham-Hutchins, Marge
    Alberts, David S.
    AMERICAN JOURNAL OF MEDICINE, 2008, 121 (06): : 475 - +
  • [27] The Predicting Factors of Bisphosphonate-related Osteonecrosis of the Jaw
    Universidade Fernando Pessoa
    1600,
  • [28] Osteonecrosis of the jaw in multiple myeloma patients.
    Raje, N.
    Woo, S.-B.
    Hande, K.
    Yap, J. T.
    Richardson, P. G.
    Vallet, S.
    Treister, N.
    Hideshima, T.
    Sheehy, N.
    Chhetri, S.
    Connell, B.
    Xie, W.
    Tai, Y. T.
    Szot-Barnes, A.
    Tian, M.
    Schlossman, R. L.
    Weller, E.
    Munshi, N. C.
    Abbeele, A. D.
    Anderson, K. C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 216 - 216
  • [29] The dilemma of jaw osteonecrosis in patients with multiple myeloma
    Gertz, Morie A.
    Koka, Sreenivas
    LEUKEMIA & LYMPHOMA, 2008, 49 (11) : 2037 - 2039
  • [30] Bisphosphonate Associated Osteonecrosis of the Jaw
    Khan, Aliya A.
    Sandor, George K. B.
    Dore, Edward
    Morrison, Archibald D.
    Alsahli, Mazen
    Amin, Faizan
    Peters, Edmund
    Hanley, David A.
    Chaudry, Sultan R.
    Lentle, Brian
    Dempster, David W.
    Glorieux, Francis H.
    Neville, Alan J.
    Talwar, Reena M.
    Clokie, Cameron M.
    Al Mardini, Majd
    Paul, Terri
    Khosla, Sundeep
    Josse, Robert G.
    Sutherland, Susan
    Lam, David K.
    Carmichael, Robert P.
    Blanas, Nick
    Kendler, David
    Petak, Steven
    Ste-Marie, Louis Georges
    Brown, Jacques
    Evans, A. Wayne
    Rios, Lorena
    Compston, Juliet E.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (03) : 478 - 490